Glutamate-induced calcium increase in myotubes depends on up-regulation of a sodium-dependent transporter  by Frank, Claudio et al.
Glutamate-induced calcium increase in myotubes depends on
up-regulation of a sodium-dependent transporter
Claudio Franka;1, Anna Maria Giammariolib;1, Loredana Falzanob, Carla Fiorentinib;,
Stefano Ru¢nic
aDepartment of Pharmacology, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161 Rome, Italy
bDepartment of Ultrastructures, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161 Rome, Italy
cDepartment of Biology, University of Rome ‘Tor Vergata’, Via della Ricerca Scienti¢ca, 00173 Rome, Italy
Received 24 May 2002; revised 25 July 2002; accepted 30 July 2002
First published online 16 August 2002
Edited by Amy M. McGough
Abstract We report a study on the regulation by 2-chloro
adenosine (2CA) of a glutamate (Glu) transporter in myogenic
C2C12 cells. Long-term 2CA exposition signi¢cantly increased
the Vmax of the Glu transporter. Moreover, 2CA-treated cells
responded to Glu challenge by a rapid and transient increase in
their intracellular calcium level. The above reported e¡ects were
totally abolished by treating C2C12 cells with the Na+-depen-
dent Glu transporter inhibitors DL-threo-b-hydroxyaspartic acid
and L-trans-pyrrolidine-2,4-dicarboxylic acid. We propose that
the possible link between the Glu uptake increase and the Glu
induction of calcium rise could be the depolarizing currents
carried by Na+ coupled with transporter activity. - 2002 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
The metabolically stable adenosine analogue 2-chloro aden-
osine (2CA) is able to induce, in the myogenic cell line C2C12,
severe changes in cell morphology and eventually cell death
[1] through a strategy not mediated by purinergic recep-
tors [2]. We have recently demonstrated that 2CA sensitizes
C2C12 cells to the excitatory amino acid glutamate (Glu) that
increases the intracellular level of calcium [3]. The data re-
ported in our previous paper ruled out an involvement of
the main Glu receptor subtypes, in the 2CA-evoked response
to Glu [3].
To elucidate the nature of the element responsive to Glu we
carried out a study in C2C12 myogenic cells taking into ac-
count the possibility that this element, induced by 2CA, could
be a Glu transporter. In fact, the Glu uptake is paralleled by
an in£ux of Naþ ions into the cells that might activate a
reverse Naþ^Ca2þ exchange, that may in turn trigger Ca2þ
release from internal stores, as described in other muscle cells
[4].
Glu transport into and out of cells is an essential part of
intra- and extracellular Glu homeostasis. This amino acid
plays a fundamental role in a variety of functions including
protein synthesis, production of energy metabolism, ammonia
¢xation, glutathione synthesis and nerve transmission [5]. Al-
tered Glu metabolism and/or decreased Glu uptake by skeletal
muscle have been observed in several pathologies, such as
malignant diseases [6], emphysema [7]. In mammalian cells,
the uptake of Glu is mediated by specialized energy-dependent
and/or passive transporters, most of which are coupled to the
cotransport of Naþ or to countertransport of Kþ [5]. The best
characterized sodium-dependent Glu transporters, belong-
ing to the system XAG activity, are the excitatory amino
acid transporters (EAATs). The four cloned transporters
(EAAC1, GLT-1, GLAST, EAAT4) have been found mainly
in the brain where they represent the principal factor that
allows the termination of Glu-mediated signal transmission.
Recently, sodium-dependent Glu uptake systems have been
identi¢ed in several cells and tissues such as ¢broblasts [8],
epithelial cells [9], macrophages [10], heart [11], placenta [12]
and in skeletal muscle as well [13,14]. Despite the limited data
available on Naþ-dependent Glu transporters in skeletal
muscle, the presence of these systems was demonstrated in
di¡erent models both in vivo [13,14] and in vitro [15]. These
transporters, although not well-characterized, share features
with Naþ/Kþ-coupled Glu transporter belonging to EAAC1
type [15]. The principal di¡erence between EACC1 and skel-
etal muscle Glu transporters resides in the di¡erent Km shown
by the two carriers (EACC1, Km =5^20 Wmol; skeletal trans-
porters, Km =500^700 Wmol). The existence of low a⁄nity
Naþ-coupled Glu uptake has been observed in a cloned mem-
ber of the Glu transporter family ASCT2 that shows a
Km = 1.6 mM. Interestingly, the molecularly well-characterized
ECC1 present in the epithelial cells line CaCo-2 shows a Km
around 120 WM [9], a value in between the low and high
a⁄nity values displayed by brain and muscle, respectively.
In this paper, we report the e¡ect of a prolonged exposure
of di¡erentiated myocytes to 2CA on the extracellular Glu-
induced intracellular Ca2þ response and propose a role for
purines also in muscle cells.
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2. Materials and methods
2.1. Cell cultures and myotube di¡erentiation
C2C12 myoblasts (American Type Culture Collection, ATCC no.
CRL-1772) were grown in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) supplemented with 20% fetal calf serum (Gibco), 100 IU/
ml penicillin and 100 Wg/ml streptomycin in a humidi¢ed atmosphere
of 5% CO2 and 95% air at 37‡C. Experiments were performed on cells
with no more than 20 passages in culture (passage 0 corresponding to
that provided by the cell supplier). Myoblasts were seeded at the
concentration of 5U105/ml in 30 mm Petri dishes and cultivated for
48 h to reach the con£uent state. Thereafter, cells were incubated in
DMEM supplemented with 2% horse serum (Gibco) (di¡erentiating
medium) for a further 48 h to induce cell di¡erentiation. At this time
point, well-organized myotubes were observed and di¡erentiation was
assessed by analysis of myosin heavy chain (MHC) expression, as
described below. All experiments were carried out with cells grown
for 48 h in di¡erentiating medium and bearing the features above
de¢ned.
2.2. Drugs and cell treatments
After 48 h in di¡erentiating medium, myotubes were exposed to 100
WM 2CA for a further 48 h (96 h total time in di¡erentiating medium).
Time of exposure and 2CA concentration were chosen on the basis of
previous studies on this adenosine analogue [1,2]. Following addition
of Glu (Research Biochemicals International) to both control and
2CA-treated cells the intracellular calcium level was evaluated as de-
scribed in Section 2.3.
To inhibit protein synthesis, myocells treated with 2CA for 30 h
were challenged with 5 Wg/ml cycloheximide (CHX) (Sigma) for 18 h
in the presence of 2CA (altogether 48 h of 2CA treatment). A speci¢c
adenosine kinase inhibitor, 5-iodotubercidin (Sigma), was added (10
nM) to cells 30 min before addition of 2CA and maintained in the
medium along the experiment. The Glu transporter inhibitors used
were: L-trans-pyrrolidine-2,4-dicarboxylic acid (PDC; Sigma), DL-
threo-b-hydroxyaspartic acid (THA; Sigma). Both were applied to
the cells by dropping in the bath solution immediately before chal-
lenge with Glu.
The depletion of internal calcium stores was obtained by challeng-
ing 2CA-treated cells with 100 WM thapsigargin (Sigma) 10 min before
addition of 1 mM Glu. In experiments in Naþ-free medium, choline
chloride (Sigma) (130 mM) substituted NaCl.
2.3. Intracellular calcium measurement
Optical £uorimetric recordings with Fura 2AM (Molecular Probe)
were utilized to evaluate the intracellular calcium concentration
([Ca2þ]i). The bath solution contained (mM): NaCl 125, KCl 1, CaCl2
5, MgCl2 1, HEPES 20, pH 7.35. Cells were bathed for 60 min at
room temperature with 5 Wg of Fura 2AM solved in 5 Wl of a solution
75% DMSO+25% pluronic acid (Molecular Probe) in 1 ml of bath
solution, at a ¢nal concentration of 5 WM. This solution was then
removed, replaced with bath solution, and the dishes were quickly
placed on the microscope plate. Glu (1 mM) was applied by directly
dropping in the bath.
To measure £uorescence changes, an Hamamatsu Argus 50 compu-
terized analysis system was used, recording each 6 s the ratio between
the values of light intensity at 340 and 380 nm stimulation.
2.4. Immunocytochemistry
C2C12 cells, grown as described above, were ¢xed with ethanol
(70%) or methanol (70%) at room temperature before incubation
with anti-MHC (Sigma). Immunocytochemistry analysis was per-
formed using Dako EnVision System Peroxidase (AEC) (Dako). Fi-
nally, coverslips were mounted and examined with a phase contrast
microscope.
2.5. Glu uptake determination
Cells for Glu uptake determination were seeded (5U104 cells/plate)
in 24-well plates and grown as described above. All experiments were
carried out at 37‡C. After incubation for 48 h in DM, myotubes were
treated for 48 h with 100 WM 2CA. Before the experiments, cells were
washed with phosphate saline bu¡er and incubated in an uptake me-
dium (137 mM NaCl, 0.7 mM K2HPO4, 1 mM CaCl2, 1 mM MgCl2,
5 mM glucose and 10 mM HEPES, pH 7.4) for 10 min. The medium
was aspirated and replaced with 250 Wl of the same bu¡er containing
0.025^3.2 mM L-Glu (Sigma) trace-labeled with 25 WCi of [U-14C]Glu
(v 250 mCi/mmol, Amersham). After 15 min, the medium was re-
moved, cells were rapidly washed twice, then lysed with 300 Wl of
20 mM NaOH in SDS 0.1%. The samples (250 Wl) were transferred
to vials containing liquid scintillation £uid (Opti£uor ^ LKB) and the
retained radioactivity was quanti¢ed by a liquid scintillation counter
(LKB 1500). Glu uptake was expressed as picomoles of Glu per milli-
gram of protein per minute. The protein content of 50 Wl of cell lysate
was determined according to Lowry [16].
Initial assays con¢rmed that the uptake was for 95% Naþ-depen-
dent (by utilizing Naþ-free medium choline-substituted bu¡er) and
linear for at least 20 min with respect to time and protein content.
3. Results
3.1. 2CA induces morphological changes and a calcium
response to Glu in C2C12 myotubes
2CA induced a dramatic alteration of the di¡erentiation
phenotype in cultured C2C12 muscle cells. We used C2C12
cells maintained in di¡erentiating medium for 48 h until the
formation of myotubes and further grown for 48 h in di¡er-
entiating medium either in the presence or in the absence of
Fig. 1. 2CA induces alterations of myotube phenotype and a Glu-
evoked calcium response in C2C12 myotubes. a: After 96 h in
DMEM with 2% horse serum, C2C12 showed the typical features
of di¡erentiated myotubes. b: 2CA exposure provokes a dramatic
alteration of the myotube morphology with the formation of en-
larged structures. c: Addition of Glu (1 mM) (white arrow) induces
a fast transient calcium response in 2CA-treated cells (graph). The
scale on the left indicates the values of ratio (340/380) and the
equivalent pseudo-color. The small pictures (A, B and C) represent
the selected cells at three di¡erent times (ca. 0, 5 and 40 min) and
the amount of calcium loading (pseudo-color). Scale bar: 10 WM.
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2CA. As shown in Fig. 1, while C2C12 control cells main-
tained in the DM for 96 h formed multinucleated myotubes
displaying aligned nuclei (Fig. 1a), 100 WM 2CA treatment
profoundly altered the myotube morphology. In fact, the cells
lost the phenotype of di¡erentiated myotubes and formed
enlarged structures containing randomly distributed nuclei
(Fig. 1b).
As previously reported [3], exposure to 2CA for 48 h ren-
dered di¡erentiated myocells sensitive to the excitatory amino
acid Glu (Fig. 1c). The application of 1 mM Glu, in fact,
evoked a powerful, fast and transient intracellular calcium
increase in 95% of cells. The number of Glu-responsive cells
dramatically decreased to 24% at a Glu concentration of 750
WM. Lower Glu concentrations (starting from 500 WM to
below) were totally ine¡ective in stimulating a calcium re-
sponse by 2CA-treated cells (data not shown).
3.2. Glu-evoked calcium increase depends on the out£ow of
calcium from the intracellular calcium stores
To de¢ne whether intracellular calcium increase was due to
an in£ux from the external medium or to a depletion of intra-
cellular calcium stores, we ¢rst substituted the calcium in the
medium with barium or alternatively added EGTA directly to
the medium. In both cases, however, 2CA-treated cells rapidly
detached from the substrate because of the loss of extracellu-
lar calcium, therefore impairing the possibility to properly
perform the experiments (data not shown). Therefore, we uti-
lized thapsigargin, the most widely used inhibitor of the ubiq-
uitous sarco-endoplasmic reticulum Ca2þ-ATPases in mam-
malian cells [17] and we monitored the exocytosis of calcium
from intracellular stores in myotubes exposed to 2CA for 48 h
(Fig. 2). Further application of Glu failed in increasing
[Ca2þ]i, suggesting that only calcium from intracellular stores
was involved.
As previously reported [2], 2CA treatment induces apopto-
tic cell death in myotubes, and cytotoxicity depends on an
intracellular phosphorylation/activation of 2CA. In this study,
we observed that a phosphorylation/activation of 2CA is also
involved in the increase of [Ca2þ]i since when the adenosine
kinase inhibitor 5-Itub (10 nM) was applied before and during
the 48 h lasting treatment with 2CA, the Glu-induced calcium
increase was signi¢cantly prevented (Fig. 2b).
3.3. A Na+-dependent transporter is necessary for Glu-
dependent calcium increase in di¡erentiated C2C12 cells
The Glu-evoked calcium increase in C2C12 cells required
the presence of Naþ in the extracellular medium (Fig. 3). Cells
pretreated with 2CA for 48 h were challenged with 1 mM Glu
and [Ca2þ]i increase was monitored by changes of Fura £uo-
rescence values in a medium containing 140 mM of Naþ or an
equimolar content of choline (Fig. 3a,b). The cells responded
to Glu with a massive increase of [Ca2þ]i, only when Naþ was
present in the medium (Fig. 3a). Otherwise, a negligible e¡ect
was recorded when Naþ was substituted by choline (Fig. 3b).
Considering that Glu-induced calcium increase in C2C12
cells is not inhibited by any of the Glu receptor antagonists
used [3] and that Naþ is an essential component of the re-
sponse to Glu, we have hypothesized that the responsive ele-
ment to Glu could be a Naþ/Glu synport system. In order to
verify this hypothesis, we inhibited the Naþ/Glu cotransporter
by using the speci¢c inhibitors PDC and THA. Both com-
pounds totally inhibited the Glu-induced [Ca2þ]i rise at
1 mM concentration (Fig. 3c,d). PDC exerted a dose-depen-
dent inhibitory activity in a concentration frame ranging from
1000 to 250 WM, showing an IC50 of about 500 WM. In con-
trast, THA retained its inhibitory activity at all the concen-
trations tested (from 1000 to 250 WM) (data not shown).
3.4. Sensitivity of di¡erentiated C2C12 cells to Glu is
dependent on the synthesis of new proteins
Naþ/Glu transporter activity is ¢nely regulated in the cells
by both translational and/or post-translational activity. To
clarify the level of the induction by 2CA of the element re-
sponsive to Glu we blocked protein synthesis by CHX. C2C12
cells pre-incubated with 100 WM 2CA in the presence of 5 Wg/
ml CHX for 18 h did not respond to challenge of Glu by
increasing their calcium concentrations (data not shown).
These data are indicative for a 2CA-induced neosynthesis of
the element responsive to Glu.
3.5. E¡ect of 2CA on Glu transport in C2C12 cells
The data obtained by monitoring the [Ca2þ]i increase were
con¢rmed by experiments carried out with radioactively la-
beled Glu (Fig. 4). To determine whether the Km or Vmax of
the Glu transporter were a¡ected by 2CA, C2C12 cells were
treated with 2CA and the kinetics of Glu uptake from cells
were measured. The Vmax of Glu uptake was signi¢cantly in-
creased after 48 h of treatment with 100 WM 2CA, from
Fig. 2. Glu mobilizes calcium from intracellular stores and its activ-
ity is mediated by adenosine kinase activity in 2CA-treated C2C12
cells. a: Depletion of internal calcium stores by 100 WM thapsigar-
gin (black arrow) induces cytosolic calcium rise. The subsequent ap-
plication of Glu (white arrow) fails in provoking an additional
[Ca2þ]i increase. b: Pretreatment of cells with 10 nM 5-iodotuberci-
din, a potent inhibitor of adenosine uptake into brain, before appli-
cation of 2CA for 48 h, signi¢cantly prevents Glu-induced calcium
increase. White arrow: Glu application.
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1.72T 0.32 nmol/min/mg cell protein in the control to
3.45T 0.28 nmol/min/mg cell protein in 2CA-treated cells.
However, the Km for Glu uptake (640T 170 WM) in sensitized
cells was not signi¢cantly di¡erent from control values
(590T 200 WM). A percentage of about 5% of the total Glu
uptake was not dependent on Naþ, as demonstrated by ex-
periments carried out in choline bu¡er. The Naþ-independent
Glu uptake was not in£uenced by cell incubation with 2CA
(data not shown).
Our data of kinetic values of Ca2þ transporter in myogenic
cells are in good agreement with those previously reported
[15].
4. Discussion
The uptake of Glu from the extracellular media mainly
depends on ion-coupled transporters. Energy for this process
is provided by the electrochemical potentials of Naþ and the
process is electrogenic [18]. It is therefore di⁄cult to deter-
mine, solely on the basis of functional experiments, which
transporters are responsible for Glu uptake in C2C12 cells.
However, the requirement of sodium in the transport process
may indicate that the Glu uptake occurs through the wide-
spread XAG system. The main disagreement between Glu
transport system in myotubes with respect to the XAG system
concerns the lower a⁄nity of the Glu transporter in C2C12
myotubes. Notably, Low and coworker hypothesized the ex-
istence of this transport system also in rat myotubes in culture
[15].
Moreover, a depolarizing current related to the transport
activity induced by the £ux of Naþ into the cell (‘transport-
associated current’) has been observed in several cells, such as
glia [19], isolated salamander Muller cells [20] and Purkinje
cells [21]. We could argue that the [Ca2þ] rise is a result of the
current £ux induced by Naþ entry. Although the movement of
ions (mainly protons and Kþ) has been described in di¡erent
cells as a response to transporters’ activity [22], no evidence
has so far been reported that calcium ions are involved in Glu
transport. We propose that in di¡erentiated C2C12 cells, the
Glu uptake-associated current could be su⁄cient to open a
‘limited’ number of voltage-activated calcium channels. The
calcium entry triggers the opening of calcium channel of the
endoplasmic reticulum and, ¢nally, a massive increase of the
intracellular level of the ions. An alternative interpretation of
our data could be that the increase of Naþ entry induces a
reverse Naþ^Ca2þ exchange and ¢nally triggers Ca2þ release
from internal stores. Experiment carried out in rabbit ventric-
ular myocytes demonstrated that reversion of the Naþ^Ca2þ
exchange can function as a trigger promoting Ca2þ release
from sarcoplasmic reticulum [23].
Fig. 3. E¡ect of Glu transporter inhibition on Glu-induced calcium increase in 2CA-treated C2C12 cells. Addition of Glu (1 mM) (white ar-
rows) induces a fast transient calcium response in 2CA-treated cells, when Naþ ions are present in the bath solution. b: When Naþ is substi-
tuted with 130 mM choline, Glu fails in inducing [Ca2þ]i increase. c, d: Pretreatment of cells with the Naþ/Glu cotransporter inhibitors THA
(c) or PDC (d) prevents the Glu-induced [Ca2þ]i rise.
Fig. 4. Exposure to 2CA increases Glu uptake in C2C12 cells. Glu
uptake was measured in myotubes growth in the absence (a) or
presence (b) of 100 WM 2CA. Representative values (meanT
S.E.M.) from a single preparation with individual points measured
in triplicate.
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Di¡erent evidences support our statement of a link between
Glu transport activity increase and Glu-induced Ca2þ in-
crease. First, a relevant percentage of free cytosolic Ca2þ
that increases after Glu addition to the cells derives from
the endoplasmic reticulum storage as demonstrated by thap-
sigargin experiments. A possible link between the current
£owing through the opening of C2C12 pores and the [Ca2þ]i
increase has been proposed by Grassi and coworkers [24].
Second, the Glu-induced [Ca2þ] increase seems to follow an
‘all or none’ mechanism. In fact, a concentration of Glu less
than 1 mM did not induce any change in the calcium entry. A
possible explanation is that a ‘threshold’ current is necessary
to induce the opening of endoplasmic Ca2þ channels, which
respond synchronously to the voltage change. Notably, both
inhibitors used in this study (t-PDC and THA) induce in
mouse astrocytes an increase in Naþ inward current that is
comparable in shape to the response to Glu-induced Naþ
inward current but is about two-fold lower in amplitude
[25]. However, both inhibitors were able to block the Glu
action on C2C12 cells, a result that can be explained only
by assuming the existence of a threshold current. Third, the
data on Glu uptake and Glu-induced calcium increase show
compatible time-courses and dose-responses. It is worth not-
ing that the results obtained by monitoring a restricted num-
ber of cells (£uorescence method) were totally overlapped by
those gained examining the whole cell population (Glu up-
take). This con¢rms the link between Glu uptake and Glu-
induced calcium increase.
The inhibitory e¡ect of CHX on the 2CA stimulation and
the apparent increase of Vmax of Glu transporters are both
consistent with the neo synthesis of ‘new’ Glu transporters.
The increase in Vmax of Glu uptake (see Section 3) might be
caused by the insertion of transporters into the plasma mem-
brane [26] or by newly synthesized transporter molecules [27].
We did not observe any changes neither in the Naþ-dependent
Glu uptake and the Glu-induced Ca2þ increase after 24 h of
C2C12 challenge with 2CA. This increase in Glu uptake sug-
gested synthesis of new proteins. The modulation of Glu up-
take by di¡erential expression of EAATs is a well-studied
topic in many cells and tissues [5]. Probably, the most impor-
tant factor for the induction of glial GLAST is the activation
of a Glu receptor [28]. However, the expression of other Glu
transporters, such as GLT from astrocytes, is not up-regu-
lated by Glu but rather by chronic treatment with growth
factors [29]. In peripheral tissues, Rimaniol et al. recently
demonstrated that in£ammatory molecules, such as tumor
necrosis factor-K, can stimulate the expression of members
of the EATTS family [30]. On the basis of our data we cannot
rule out the idea that the up-regulation of Glu uptake after
2CA administration could depend on other newly synthesized
proteins other than Glu transporters. In fact, the mechanism
of membrane insertion of a cytosolic pool of transporters is in
itself a complex and sophisticated mechanism, which involves
a transduction system not yet well-de¢ned. Thus, these regu-
latory proteins might be the target of 2CA. Interestingly, Low
and coworkers demonstrated in cultured rat myotubes the
existence of adaptive up-regulation of Glu transporter in re-
sponse to glutamine deprivation. In Low’s paper it is not clear
whether the up-regulation of Glu transporter is dependent on
a stress situation or on a more ¢nely regulated mechanism.
Taking into account the physiological relevance of Glu up-
take in muscle cells, a more detailed study on the molecular
nature of the 2CA-inducible Glu-responsive element is man-
datory. The up-regulation of Glu transport might represent
the target mechanism for a pharmacological approach to cer-
tain muscular disorders.
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